Why This Meeting Remains the Priority for Your Biopharma Peers
Remaining your longest-standing, global forum for the precision medicine community, the 16th World Clinical Biomarkers & Companion Diagnostics Summit continues to unite biopharma, diagnostic, regulatory, healthcare, testing labs and multimodal organizations year after year. Find out exactly why your peers are keen to join us once more.
"This summit delivered high quality speakers and case studies showing the challenges associated with CDx from development through to reimbursement, that will guide me in biomarker strategies for future studies"
Volunteer, American Cancer Society
"The congress is a great opportunity to meet with our precision medicine peers in the industry and share best practices"
Director, Precision Medicine & Global Diagnostics Strategy, Amgen
"This forum offers great networking opportunities across diagnostics, pharma, and biosample vendors. I appreciate the opportunity to cross paths with this global network and the ample time to connect"
Director, Translational Medicine Strategy, AstraZeneca
"This conference facilitates many valuable discussions with potential partners. I like the fact that the conference keeps getting a little bit larger every year and that it continues to attract larger and larger precision medicine vendors"
Director, Diagnostics, Bristol Myers Squibb
"This meeting offered hyper relevant presentation topics and extensive expertise across the pharma and diagnostics space"
Head, Companion Diagnostics Development, Genentech
"It was incredible having many Dx and Rx partners together at World CB & CDx. The ease of scheduling meetings and having the calendar to put talks and meetings into was helpful to engage in both the content and networking"
Principle Investigator, Research, Incyte
"Through case studies and thought leader engagement, this meeting provides an opportunity to network directly with the diagnostic manufacturers that offer potential solutions for translational studies and clinical trials"
Senior Director, Global Regulatory Affairs, Digital Health & Drug Delivery, Eli Lilly
"As in the past, this summit provided a wide range of topics for the different audience members covering all stages of the CDx lifecycle. The real-life examples and case studies shared by presenters were insightful and helpful in providing potential mitigation strategies, should our organizations fall into similar scenarios. Alongside this, the venue, snacks, and opportunities to network were great"
Director, Vendor Quality & Good Clinical Practice, Regeneron Pharmaceuticals
"Uniquely, the World CB & CDx meeting has all current and potential future diagnostics partners in one space to discuss collaborations. Hearing about all the new IVD innovations in the space makes this the best conference for me and my team"
Senior Director, IVD Development Lead, Sanofi
Delve into the Brand-New Agenda
- Free* Attendance for Representatives from Biopharma & Academia
- Your Globally Leading Biomarker & Companion Diagnostics Forum
- Access Numerous Strategic Rx-Dx Co-Development & Partnership Selection Panels
- Partake in Multiple Biomarker Sessions Spanning Oncology, Hematology & Neurological, Chronic, Autoimmune & Rare Diseases
- Discover Brand-New Case Studies on Digital Pathology, Multimodal Data & AI-Enabled Precision Medicine
- Take Advantage of Unmatched, Exclusive Networking & Partnerships Opportunities
Explore the New Agenda
Hear the latest imaging, multi-omics, single-cell and functional assays, enhanced by AI-driven digital biomarker strategies, enabling earlier and smarter treatment decisions for oncology, autoimmune, neurological, chronic and rare disease patients
Partner with Us
Position your solutions alongside leading biomarker, diagnostic and technology providers, to ensure your brand is front and center, and retain your place as the partner of choice in the ever-expanding precision medicine space
Join 850+ Specialist Experts
Be part of the liveliest Rx-Dx conversations with like-minded industry peers spanning a range of precision therapy modalities, and build high-value connections during dedicated networking sessions designed to foster collaborations